ChemoCentryx, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 78 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-18: Reporting owner Cappel Markus J.; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-18: Reporting owner Cappel Markus J.; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-18: Reporting owner Jaen Juan C.; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-17: Reporting owner Jaen Juan C.; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-18 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,060 44,120 owned after | $0.60 exercise price | 2012-12-20 | |
| 2012-12-18 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,783 41,085 owned after | $4.30 exercise price | 2012-12-20 | |
| 2012-12-18 | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 182,500 owned after | $4.30 exercise price | 2012-12-19 | |
| 2012-12-17 | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 190,000 owned after | $4.30 exercise price | 2012-12-19 | |
| 2012-12-04 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,693 177,500 owned after | $2.00 exercise price | 2012-12-04 | |
| 2012-12-03 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −404 182,193 owned after | $2.00 exercise price | 2012-12-04 | |
| 2012-11-30 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −830 182,597 owned after | $2.00 exercise price | 2012-12-04 | |
| 2012-11-29 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,839 183,427 owned after | $2.00 exercise price | 2012-11-30 | |
| 2012-11-28 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −234 187,266 owned after | $2.00 exercise price | 2012-11-30 | |
| 2012-11-26 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −201 47,180 owned after | $0.60 exercise price | 2012-11-28 | |
| 2012-11-23 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −390 42,868 owned after | $4.30 exercise price | 2012-11-26 | |
| 2012-11-23 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −405 47,381 owned after | $0.60 exercise price | 2012-11-26 | |
| 2012-11-21 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,393 43,258 owned after | $4.30 exercise price | 2012-11-26 | |
| 2012-11-20 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3 47,786 owned after | $0.60 exercise price | 2012-11-21 | |
| 2012-11-19 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7 47,789 owned after | $0.60 exercise price | 2012-11-21 | |
| 2012-11-19 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,561 50,939 owned after | $0.60 exercise price | 2012-11-20 | |
| 2012-11-06 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,300 57,500 owned after | $0.60 exercise price | 2012-11-08 | |
| 2012-11-06 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 52,500 owned after | $0.60 exercise price | 2012-11-08 | |
| 2012-11-06 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,676 47,796 owned after | $0.60 exercise price | 2012-11-08 | |
| 2012-11-06 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,029 197,500 owned after | $2.00 exercise price | 2012-11-08 | |
| 2012-11-06 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 187,500 owned after | $2.00 exercise price | 2012-11-08 | |
| 2012-10-22 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −316 51,472 owned after | $0.60 exercise price | 2012-10-22 | |
| 2012-10-19 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,900 51,788 owned after | $0.60 exercise price | 2012-10-22 | |
| 2012-10-18 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,136 54,688 owned after | $0.60 exercise price | 2012-10-22 | |
| 2012-10-18 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,566 44,651 owned after | $4.30 exercise price | 2012-10-22 | |
| 2012-10-01 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,971 203,529 owned after | $2.00 exercise price | 2012-10-03 | |
| 2012-09-25 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,676 58,824 owned after | $0.60 exercise price | 2012-09-27 | |
| 2012-09-25 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,783 48,217 owned after | $4.30 exercise price | 2012-09-27 | |
| 2012-09-24 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100 61,800 owned after | $0.60 exercise price | 2012-09-24 | |
| 2012-09-20 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −200 61,900 owned after | $0.60 exercise price | 2012-09-24 | |
| 2012-09-17 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 62,100 owned after | $0.60 exercise price | 2012-09-19 | |
| 2012-07-24 | Schall Thomas J. Director, Officer (President and CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +485,088 485,088 owned after | $14.31 exercise price | 2012-07-26 | |
| 2012-07-24 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +121,166 121,166 owned after | $14.31 exercise price | 2012-07-26 | |
| 2012-07-24 | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,664 110,664 owned after | $14.31 exercise price | 2012-07-26 | |
| 2012-07-24 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +123,156 123,156 owned after | $14.31 exercise price | 2012-07-26 | |
| 2012-07-24 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +104,289 104,289 owned after | $14.31 exercise price | 2012-07-26 | |
| 2012-06-22 | PENHOET EDWARD Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.42 exercise price | 2012-06-26 | |
| 2012-06-22 | LUCAS ROGER C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.42 exercise price | 2012-06-26 | |
| 2012-06-22 | Tyree James L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.42 exercise price | 2012-06-26 | |
| 2012-06-22 | Parker Geoffrey M. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.42 exercise price | 2012-06-26 | |
| 2012-06-22 | Gupta Rishi Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.42 exercise price | 2012-06-26 | |
| 2012-06-22 | FECZKO JOSEPH M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $14.42 exercise price | 2012-06-26 | |
| 2012-06-05 | Tyree James L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $12.62 exercise price | 2012-06-07 | |
| 2012-04-25 | FECZKO JOSEPH M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $15.90 exercise price | 2012-04-27 | |
| 2012-02-27 | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,712 24,712 owned after | $10.27 exercise price | 2012-02-29 | |
| 2012-02-27 | KANAYA SUSAN M Officer (SVP, Finance, CFO and Sec.) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,090 22,090 owned after | $10.27 exercise price | 2012-02-29 | |
| 2012-02-27 | Cappel Markus J. Officer (Chief Bus. Officer & Treasurer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,348 24,348 owned after | $10.27 exercise price | 2012-02-29 | |
| 2012-02-27 | Schall Thomas J. Director, Officer (President and CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $10.27 exercise price | 2012-02-29 | |
| 2012-02-27 | Bekker Petrus Officer (SVP of Medical & Clinical) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +19,632 19,632 owned after | $10.27 exercise price | 2012-02-29 | |
| 2012-02-08 holding as of filing | Parker Geoffrey M. Director | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Bekker Petrus Officer (SVP of Med & Clinical Affairs) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $0.60 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Bekker Petrus Officer (SVP of Med & Clinical Affairs) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Bekker Petrus Officer (SVP of Med & Clinical Affairs) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Bekker Petrus Officer (SVP of Med & Clinical Affairs) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Bekker Petrus Officer (SVP of Med & Clinical Affairs) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.30 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Bekker Petrus Officer (SVP of Med & Clinical Affairs) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.90 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $4.30 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.30 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Jaen Juan C. Officer (SVP, Drug Discovery & CSO) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.90 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | KANAYA SUSAN M Officer (SVP Finance, CFO & Secretary) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $2.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | KANAYA SUSAN M Officer (SVP Finance, CFO & Secretary) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | KANAYA SUSAN M Officer (SVP Finance, CFO & Secretary) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | KANAYA SUSAN M Officer (SVP Finance, CFO & Secretary) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.30 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | KANAYA SUSAN M Officer (SVP Finance, CFO & Secretary) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.90 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Cappel Markus J. Officer (CBO and Treasurer) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $0.60 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Cappel Markus J. Officer (CBO and Treasurer) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $0.60 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Cappel Markus J. Officer (CBO and Treasurer) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $4.30 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Cappel Markus J. Officer (CBO and Treasurer) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Cappel Markus J. Officer (CBO and Treasurer) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Cappel Markus J. Officer (CBO and Treasurer) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.30 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Cappel Markus J. Officer (CBO and Treasurer) | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.90 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Schall Thomas J. Director, Officer (President, CEO and Director), 10% Owner | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $0.60 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Schall Thomas J. Director, Officer (President, CEO and Director), 10% Owner | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $0.60 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Schall Thomas J. Director, Officer (President, CEO and Director), 10% Owner | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Schall Thomas J. Director, Officer (President, CEO and Director), 10% Owner | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.00 exercise price | 2012-02-08 | ||
| 2012-02-08 holding as of filing | Schall Thomas J. Director, Officer (President, CEO and Director), 10% Owner | 3 | Employee Stock Option (right to buy) Derivative · Direct | Holding | $6.30 exercise price | 2012-02-08 |